These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 161940)
21. [Hypoglycemic accidents during treatment with antidiabetic sulfamides. Apropos of 5 cases of hypoglycemic coma in aged subjects]. Brogard JM; Kuntzmann F; Touitou D; Dorner M Sem Hop; 1973 Sep; 49(37):2461-6. PubMed ID: 4359498 [No Abstract] [Full Text] [Related]
22. Oral hypoglycemic agents. Ferner RE Med Clin North Am; 1988 Nov; 72(6):1323-35. PubMed ID: 3054355 [TBL] [Abstract][Full Text] [Related]
23. [Therapy of diabetes in adults using Glibornurid. Results and clinical studies]. Schöffling K; Mehnert H; Ewald W; Haupt E; Wicklmayr M; Beyer J; Nemeth N Dtsch Med Wochenschr; 1973 May; 98(18):915-9. PubMed ID: 4633717 [No Abstract] [Full Text] [Related]
24. [Clinico-statistical studies of the use of oral hypoglycemic agents in the therapy of diabetes: critical evaluation of their effectiveness and tolerance]. Torri A; Zanni A; Roncaia R; Di Saverio S Clin Ter; 1977 Jul; 82(1):45-56. PubMed ID: 409583 [No Abstract] [Full Text] [Related]
25. Use oral hypoglycemics with caution.. Jackson JE; Bressler R Geriatrics; 1988 Aug; 43(8):77-83. PubMed ID: 3136057 [No Abstract] [Full Text] [Related]
26. [Clinical testing of a sulfonylurea preparation (glibenclamide)]. Sigroth K; Steen B; Svanborg A Lakartidningen; 1969 Nov; 66(45):4647-50. PubMed ID: 4996889 [No Abstract] [Full Text] [Related]
27. Clinical experiences in oral antidiabetic therapy with sulphonylureas and biguanides. Schöffling K Aust N Z J Med; 1971 Aug; 1():Suppl 2:47-56. PubMed ID: 5005131 [No Abstract] [Full Text] [Related]
28. An open comparative study of the efficacy and tolerance of a new antidiabetic agent: glipizide. De Leeuw I; De Baere H; Decraene P; Lemmens P; Verhaegen H Diabetologia; 1973 Sep; ():364-6. PubMed ID: 4204093 [No Abstract] [Full Text] [Related]
30. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide). Loubatiéres A; Mariani MM; Ribes G; Alric R Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675 [No Abstract] [Full Text] [Related]
31. [Effect of a new oral drug in the treatment of diabetes mellitus]. Lubetzki J Diabete; 1971; 19(3):185-90. PubMed ID: 5002990 [No Abstract] [Full Text] [Related]
33. [Diabetes therapy using oral antidiabetics]. Hasslacher C; Wahl P Z Allgemeinmed; 1972 Apr; 48(12):583-7. PubMed ID: 5034166 [No Abstract] [Full Text] [Related]
34. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus]. Polosa P; Mughini L Minerva Med; 1974 Aug; 65(59):383-9. PubMed ID: 4213556 [No Abstract] [Full Text] [Related]
35. [Clinical study of a new sulfonylurea antidiabetic, glibornuride]. Vernet A; Fabre J; Zahnd G Schweiz Rundsch Med Prax; 1972 Dec; 61(52):1599-607. PubMed ID: 4630563 [No Abstract] [Full Text] [Related]
36. The clinical evaluation of an oral antidiabetic drug. Müller R Aust N Z J Med; 1971 Aug; 1():Suppl 2:39-46. PubMed ID: 5005130 [No Abstract] [Full Text] [Related]
37. [Clinical testing of a sulphonylurea derivative, glibornuride]. Zöllner N; Dörfler H; Wolfram G Dtsch Med Wochenschr; 1972 Jul; 97(29):1083-8. PubMed ID: 4625427 [No Abstract] [Full Text] [Related]
38. [Glibenclamide, a new oral antidiabetic]. Edlén A Lakartidningen; 1972 Jan; 69(4):342-3. PubMed ID: 4622487 [No Abstract] [Full Text] [Related]
39. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment. Harrigan RA; Nathan MS; Beattie P Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816 [TBL] [Abstract][Full Text] [Related]